Results 251 to 260 of about 1,140,223 (331)
Engineering antibodies with cancer‐associated binding sites
This review describes antibodies that perform direct/indirect roles in cancer treatment by binding to effective targets and discusses how antibodies kill tumors and modulate tumor microenvironment through these targets. The classification of expression systems for antibody production is summarized to guide appropriate selection based on different ...
Yinqi Tian+4 more
wiley +1 more source
Papillary Renal Cell Carcinoma With Widespread Metastases in an Arabian Mare. [PDF]
Azari O+6 more
europepmc +1 more source
CLINICAL STUDIES ON RENAL CELL CARCINOMA AS AN INCIDENTAL FINDING
Tetsuro Onishi+7 more
openalex +2 more sources
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan+12 more
wiley +1 more source
Renal cell carcinoma accompanied by aldosterone-secreting contralateral adrenal metastasis: a case report. [PDF]
Doyya M, Alloush G, Alloush M.
europepmc +1 more source
ENHANCING CYTOTOXICITY OF VINBLASTINE BY NICARDIPINE IN RENAL CELL CARCINOMA
Mitsunobu Masuda
openalex +2 more sources
The accessory renal arteries: A systematic review with meta‐analysis
Abstract The accessory renal arteries (ARAs) are a well‐described variant of the renal vasculature with clinical implications for radiologists, surgeons, and clinicians. The aim of the present systematic review with meta‐analysis was to estimate the pooled prevalence of ARAs, including their variant number, origin, and termination, and to highlight ...
George Triantafyllou+6 more
wiley +1 more source
Abstract Background The combined use of anti‐programmed cell death protein 1 (PD‐1)/anti‐cytotoxic T‐lymphocyte associated protein 4 (CTLA‐4) checkpoint inhibitors has been effective in various cancer types. The Southwest Oncology Group (SWOG) Dual Anti‐CTLA‐4 and Anti‐PD‐1 Blockade in Rare Tumors (DART) S1609 study investigated ipilimumab and ...
Young Kwang Chae+16 more
wiley +1 more source
Abstract Background Tumor‐associated neutrophils (TANs) play a critical role in modulating immune responses and exhibit significant heterogeneity. Our previous study demonstrated that jagged canonical Notch ligand 2 (JAG2)+ TANs were associated with an immunosuppressive microenvironment in high‐grade serous ovarian cancer (HGSOC), but the underlying ...
Chenyang Wang+11 more
wiley +1 more source